1 Report Prologue
2 Executive Summary
3 Market Introduction
3.1 Definition 18
3.2 Scope of the Study 18
3.3 Research Objective 18
3.4 Assumptions & Limitations 18
3.4.1 Assumptions 18
3.4.2 Limitations 18
3.5 Market Structure 19
4 Research Methodology
4.1 Research Process 21
4.2 Primary Research 22
4.3 Secondary Research 23
4.4 Market Size Estimation 24
4.5 Forecast Model 24
5 Market Dynamics
5.1 Introduction 26
5.2 Drivers 27
5.2.1 Greater Sterility Assurance of Pharmaceutical Isolators 27
5.2.2 Low Operational Cost of Pharmaceutical Isolators 27
5.3 Restraints 27
5.3.1 Availability of Restricted Access Barrier Systems (RABS) for Aseptic Processing 27
5.4 Opportunities 28
5.4.1 Technological Advancements in Pharmaceutical Isolators 28
6 Market Factor Analysis
6.1 Porter’s Five Forces Model 30
6.1.1 Bargaining Power of Suppliers 30
6.1.2 Bargaining Power of Buyers 30
6.1.3 Threat of New Entrants 31
6.1.4 Threat of Substitutes 31
6.1.5 Intense Rivalry 31
6.2 Supply chain analysis 32
6.2.1 R&D and Designing 32
6.2.2 Manufacturing 32
6.2.3 Distribution & Sales 32
6.2.4 Post-Sales Monitoring 32
7 Pharmaceutical Isolator Market, By Type
7.1 Overview 34
7.2 Open Isolator 35
7.3 Closed Isolator 36
8 Pharmaceutical Isolator Market, By Pressure
8.1 Overview 38
8.2 Positive Pressure 39
8.3 Negative Pressure 40
9 Global Pharmaceutical Isolator Market by Application
9.1 Overview 42
9.2 Aseptic Filling 43
9.3 Fluid Dispensing 44
9.4 Sampling/Weighing/Distribution 44
9.5 Product Containment 45
10 Global Pharmaceutical Isolator Market by End-User
10.1 Overview 47
10.2 Pharmaceutical & Biotechnology Companies 48
10.3 Hospitals 49
10.4 Research & Academic Laboratories 49
11 Global Pharmaceutical Isolator Market, by Region
11.1 Introduction 51
11.2 Americas 52
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.2.1 North America 54
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.2.1.1 US 56
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.2.1.2 Canada 57
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.2.2 South America 59
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3 Europe 61
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1 Western Europe 63
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.1 Germany 65
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.2 France 67
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.3 UK 68
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.4 Italy 69
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.5 Spain 71
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.1.6 Rest of Western Europe 72
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.3.2 Eastern Europe 73
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4 Asia Pacific 75
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.1 Japan 77
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.2 China 78
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.3 India 80
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.4 Australia 81
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.5 South Korea 82
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.4.6 Rest of Asia-Pacific 84
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.5 The Middle East and Africa 85
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.5.1 Middle East 87
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
11.5.2 Africa 88
Pharmaceutical Isolator Market, By Type
Pharmaceutical Isolator Market, By Pressure
12 Competitive Landscape
12.1 Overview 91
13 Company Profiles
13.1 Gelman Singapore Pte Ltd. 93
13.1.1 Company Overview 93
13.1.2 Financial Overview 93
13.1.3 Products Offering 93
13.1.4 SWOT Analysis 93
13.1.5 Key Developments 93
13.1.6 Key strategy 93
13.2 COMECER S.p.A. cf. p.iva 94
13.2.1 Company Overview 94
13.2.2 Financial Overview 94
13.2.3 Products Offering 94
13.2.4 SWOT Analysis 95
13.2.5 Key Developments 95
13.2.6 Key strategy 95
13.3 IsoTech Design 96
13.3.1 Company Overview 96
13.3.2 Company Overview 96
13.3.3 Products Offering 96
13.3.4 SWOT Analysis 97
13.3.5 Key Developments 97
13.3.6 Key strategy 97
13.4 LAF Technologies Pty Ltd. 98
13.4.1 Company Overview 98
13.4.2 Financial Overview 98
13.4.3 Products Offering 98
13.4.4 SWOT Analysis 98
13.4.5 Key Developments 98
13.4.6 Key Strategy 99
13.5 Fedegari Autoclavi S.p.A 100
13.5.1 Company Overview 100
13.5.2 Financial Overview 100
13.5.3 Products Offering 100
13.5.4 SWOT Analysis 100
13.5.5 Key Developments 101
13.5.6 Key Strategy 101
13.6 Hosokawa Micron Ltd 102
13.6.1 Company Overview 102
13.6.2 Financial Overview 102
13.6.3 Products Offering 103
13.6.4 SWOT Analysis 103
13.6.5 Key Development 103
13.6.6 Key Strategy 103
13.7 Robert Bosch GmbH 104
13.7.1 Company Overview 104
13.7.2 Financial Overview 104
13.7.3 Products Offering 105
13.7.4 SWOT Analysis 105
13.7.5 Key Development 105
13.7.6 Key Strategy 105
13.8 MBRAUN 106
13.8.1 Company Overview 106
13.8.2 Financial Overview 106
13.8.3 Products Offering 106
13.8.4 SWOT Analysis 107
13.8.5 Key Development 107
13.8.6 Key Strategy 107
13.9 Schematic Engineering Industries 108
13.9.1 Company Overview 108
13.9.2 Financial Overview 108
13.9.3 Products Offering 108
13.9.4 SWOT Analysis 108
13.9.5 Key Development 109
13.9.6 Key Strategy 109
13.9.7 NuAire Inc. 110
13.9.8 Company Overview 110
13.9.9 Financial Overview 110
13.9.10 Products Offering 110
13.9.11 SWOT Analysis 110
13.9.12 Key Development 110
13.9.13 Key Strategy 110
13.10 VanRx Pharmasystems Inc. 111
13.10.1 Company Overview 111
13.10.2 Financial Overview 111
13.10.3 Products Offering 111
13.10.4 SWOT Analysis 111
13.10.5 Key Developments 112
13.10.6 Key strategy 112
13.11 Azbil Telstar 113
13.11.1 Company Overview 113
13.11.2 Financial Overview 113
13.11.3 Products Offering 114
13.11.4 SWOT Analysis 114
13.11.5 Key Development 114
13.11.6 Key Strategy 114
13.12 Getinge AB 115
13.12.1 Company Overview 115
13.12.2 Financial Overview 115
13.12.3 Products Offering 116
13.12.4 SWOT Analysis 116
13.12.5 Key Development 116
13.12.6 Key Strategy 116
13.13 Skan AG 117
13.13.1 Company Overview 117
13.13.2 Financial Overview 117
13.13.3 Products Offering 117
13.13.4 SWOT Analysis 117
13.13.5 Key Development 117
13.13.6 Key Strategy 118
14 Appendix
14.1 Discussion Blue Print 120
15 List of Tables
TABLE 1 MARKET SYNOPSIS 16
TABLE 2 PRIMARY INTERVIEWS 21
TABLE 3 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020-2027 (USD MILLION) 35
TABLE 4 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR OPEN ISOLATOR BY REGION, 2020 TO 2027 (USD MILLION) 35
TABLE 5 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR CLOSED ISOLATOR BY REGION, 2020 TO 2027 (USD MILLION) 36
TABLE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 39
TABLE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR POSITIVE PRESSURE BY REGION, 2020 TO 2027 (USD MILLION) 39
TABLE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR NEGATIVE PRESSURE BY REGION, 2020 TO 2027 (USD MILLION) 40
TABLE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 43
TABLE 10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR ASEPTIC FILLING BY REGION, 2020 TO 2027 (USD MILLION) 43
TABLE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR FLUID DISPENSING BY REGION, 2020 TO 2027 (USD MILLION) 44
TABLE 12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR SAMPLING/WEIGHING/DISTRIBUTION BY REGION, 2020 TO 2027 (USD MILLION) 44
TABLE 13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR PRODUCT CONTAINMENT BY REGION, 2020 TO 2027 (USD MILLION) 45
TABLE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 48
TABLE 15 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES BY REGION, 2020 TO 2027 (USD MILLION) 48
TABLE 16 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR HOSPITALS BY REGION, 2020 TO 2027 (USD MILLION) 49
TABLE 17 GLOBAL PHARMACEUTICAL ISOLATOR MARKET FOR RESEARCH AND ACADEMIC LABORATORIES BY REGION, 2020 TO 2027 (USD MILLION) 49
TABLE 18 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 51
TABLE 19 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 52
TABLE 20 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 53
TABLE 21 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 53
TABLE 22 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 53
TABLE 23 AMERICAS PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 54
TABLE 24 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 54
TABLE 25 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 55
TABLE 26 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 55
TABLE 27 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 55
TABLE 28 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 56
TABLE 29 US PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 56
TABLE 30 US PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 56
TABLE 31 US PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 57
TABLE 32 US PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 57
TABLE 33 CANADA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 57
TABLE 34 CANADA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 58
TABLE 35 CANADA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 58
TABLE 36 CANADA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 58
TABLE 37 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 59
TABLE 38 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 59
TABLE 39 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 59
TABLE 40 SOUTH AMERICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 60
TABLE 41 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 61
TABLE 42 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 62
TABLE 43 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 62
TABLE 44 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 62
TABLE 45 EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 63
TABLE 46 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 64
TABLE 47 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 64
TABLE 48 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 64
TABLE 49 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 65
TABLE 50 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 65
TABLE 51 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 65
TABLE 52 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 66
TABLE 53 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 66
TABLE 54 GERMANY PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 66
TABLE 55 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 67
TABLE 56 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 67
TABLE 57 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 67
TABLE 58 FRANCE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 68
TABLE 59 UK PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 68
TABLE 60 UK PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 68
TABLE 61 UK PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 69
TABLE 62 UK PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 69
TABLE 63 ITALY PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 69
TABLE 64 ITALY PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 70
TABLE 65 ITALY PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 70
TABLE 66 ITALY PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 70
TABLE 67 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 71
TABLE 68 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 71
TABLE 69 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 71
TABLE 70 SPAIN PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 72
TABLE 71 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 72
TABLE 72 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 72
TABLE 73 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 73
TABLE 74 REST OF WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 73
TABLE 75 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 73
TABLE 76 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 74
TABLE 77 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 74
TABLE 78 EASTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 74
TABLE 79 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY COUNTRY, 2020 TO 2027 (USD MILLION) 75
TABLE 80 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 76
TABLE 81 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 76
TABLE 82 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 76
TABLE 83 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 77
TABLE 84 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 77
TABLE 85 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 77
TABLE 86 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 78
TABLE 87 JAPAN PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 78
TABLE 88 CHINA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 78
TABLE 89 CHINA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 79
TABLE 90 CHINA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 79
TABLE 91 CHINA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 79
TABLE 92 INDIA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 80
TABLE 93 INDIA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 80
TABLE 94 INDIA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 80
TABLE 95 INDIA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 81
TABLE 96 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 81
TABLE 97 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 81
TABLE 98 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 82
TABLE 99 AUSTRALIA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 82
TABLE 100 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 82
TABLE 101 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 83
TABLE 102 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 83
TABLE 103 SOUTH KOREA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 83
TABLE 104 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 84
TABLE 105 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 84
TABLE 106 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 84
TABLE 107 REST OF ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 85
TABLE 108 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 TO 2027 (USD MILLION) 85
TABLE 109 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 86
TABLE 110 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 86
TABLE 111 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 86
TABLE 112 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 87
TABLE 113 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 87
TABLE 114 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 87
TABLE 115 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 88
TABLE 116 MIDDLE EAST PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 88
TABLE 117 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 TO 2027 (USD MILLION) 88
TABLE 118 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 TO 2027 (USD MILLION) 89
TABLE 119 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 TO 2027 (USD MILLION) 89
TABLE 120 AFRICA PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 TO 2027 (USD MILLION) 89
16 List of Figures
FIGURE 1 RESEARCH PROCESS 21
FIGURE 2 TOP-DOWN & BOTTOM-UP APPROACH 24
FIGURE 3 MARKET DYNAMICS ANALYSIS OF GLOBAL PHARMACEUTICAL ISOLATOR MARKET 26
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PHARMACEUTICAL ISOLATOR MARKET 30
FIGURE 5 SUPPLY CHAIN: GLOBAL PHARMACEUTICAL ISOLATOR MARKET 32
FIGURE 6 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY TYPE, 2020 (%) 34
FIGURE 7 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY TYPE, 2020 & 2027 (USD MILLION) 34
FIGURE 8 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY PRESSURE, 2020 (%) 38
FIGURE 9 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY PRESSURE, 2020 & 2027 (USD MILLION) 38
FIGURE 10 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY APPLICATION, 2020 (%) 42
FIGURE 11 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY APPLICATION, 2020 & 2027 (USD MILLION) 42
FIGURE 12 GLOBAL PHARMACEUTICAL ISOLATOR MARKET SHARE, BY END-USER, 2020 (%) 47
FIGURE 13 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY END-USER, 2020 & 2027 (USD MILLION) 47
FIGURE 14 GLOBAL PHARMACEUTICAL ISOLATOR MARKET BY REGION, 2020 & 2027 (USD MILLION) 51
FIGURE 15 AMERICAS PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 52
FIGURE 16 NORTH AMERICA PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 54
FIGURE 17 EUROPE PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 61
FIGURE 18 WESTERN EUROPE PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 63
FIGURE 19 ASIA-PACIFIC PHARMACEUTICAL ISOLATOR MARKET SHARE BY COUNTRY, 2020 (%) 75
FIGURE 20 MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET SHARE BY REGION, 2020 (%) 85
医薬品アイソレータ市場
医薬品アイソレータ市場は年平均成長率 7.15% で成長し、2030年までに1,80.15万ドルに達する
$180.15 Million
市場規模
7.15%
CAGR
North America
支配的な地域
2022-2030
予測期間
セグメンテーション
キープレーヤー
- AzbilTelstarSkanAGGetinge AB
- VanRxPharmasystems Inc.
- Schematic Engineering Industries
- NuAire Inc.
- Robert Bosch GmbH
- MBRAUN
- FedegariAutoclaviSpA
- Hosokawa Micron Ltd
- IsoTech Design
- COMECER SpA cf. p.iva
運転手
- The immense sterility assurance of pharmaceutical isolators results
- low operational costs
医薬品アイソレータ市場の概要
医薬品アイソレータ市場は、最近最も急速に発展している市場であり、近い将来、さらなる高みへと推進されるでしょう。市場価値は、2023年までに約32,94430万米ドルに達すると推定されています。複合年間成長率（CAGR）は、2017年から2023年までの予測期間で7.86％になると予測されています。
医薬品アイソレータは、製造プロセスやその他の製品取り扱い手順中のあらゆる種類の汚染を防ぐ目的で特別に設計されています。医薬品アイソレータ市場は、薬剤の暴露からオペレーターを保護し、相互汚染の可能性を排除し、医薬品の品質基準を維持することを可能にします。医薬品アイソレータ業界では、製品製造プロセス中に細心の注意を払うことが非常に重要です。医薬品市場におけるさまざまなタイプのアイソレータは、製品製造プロセスにおいて最適なレベルの無菌性を提供します。ホルモン、細胞増殖抑制剤、抗生物質などの効能の高い成分を含む医薬品の製造には、市場規模の拡大を促進するより高いレベルの予防策が必要です。
製薬用アイソレータのベンダーは、アイソレータを高価格で販売することすらなく、実際、これらのアイソレータは従来のクリーンルームよりもはるかに実現可能です。消毒されたクリーンルームでは、オペレーターが限られた量の汚染をもたらす可能性があります。しかし、製薬用アイソレータ業界のアイソレータは、医薬品や材料が製造プロセスシステムに直接接触することしか許されないバイオ汚染除去環境を提供します。これらの機能はすべて、医薬品アイソレータ市場の成長を促進し、予測期間中に最大の高さを達成するのに役立ちます。製薬業界と医薬品製造の需要の高まり、研究開発作業における支出の増加、および医薬品の安全性と有効性を維持するための厳格な政府の政策と規制は、市場の可能性の増大につながります。
レポートは、世界市場の詳細な分析と、COVID19パンデミックが市場に与える影響を強調しています。予測期間中に市場を牽引する市場のダイナミクスと主要なプレーヤーをカバーしています。レポートは市場の細分化を説明し、近い将来の医薬品アイソレータ市場の成長に影響を与える可能性のあるさまざまな地域に光を当てています。
COVID19 分析
コロナウイルスの発生は、健康だけでなく経済の分野でも大きな危機をもたらしました。世界経済の成長率は最低限まで減速した。厳しいロックダウン措置により、多くの製造業が停止しました。しかし、コロナウイルスが世界中で健康危機を引き起こしたため、ヘルスケア部門は依然として需要がありました。健康問題への懸念により、医薬品の需要が高まり、製薬業界の成長が激化しました。製薬業界と医薬品製造プロセスが日々成長しているため、医薬品アイソレーター市場の需要も高まっています。製薬アイソレータ業界は安定した成長率を維持し、世界経済に大きく貢献しました。
世界的な健康危機は、病気から回復するために大量の医薬品を生産し、その目的を達成するために世界中で製造される新薬の急増を必要としました。医薬品の製造には、市場が提供できる徹底的な注意と適切な取り扱い、および市場の成長の進化に伴う製造プロセスの増加が必要です。今後数年間で、医薬品アイソレータ市場の需要はさらに高まり、最適な限界に達するでしょう。
マーケットダイナミクス
- 市場の主な推進力
医薬品アイソレータ市場の成長は世界経済で急上昇しており、製薬セクターは市場の主要な原動力です。医薬品アイソレータの無菌性が非常に保証されることで、市場規模が拡大します。製造プロセスの準備には、高い効力を持ち、ホルモン、抗生物質、細胞増殖抑制性などの物質を含む有効医薬品成分またはAPIの関与が含まれます。これらのプロセスには、あらゆる種類の汚染を避けるために細心の注意と安全対策が必要であり、市場は必要な量の製品安全性を正確に提供します。医薬品アイソレータ技術市場は、オペレータの安全を確保し、最終製品の品質基準を維持する安全な環境へのアクセスを可能にします。
医薬品アイソレータ市場の成長のもう一つの効率的な推進力は、運用コストの低さです。製薬用アイソレータのベンダーは、従来のクリーンルームに比べてはるかに安い料金でアイソレータを製薬業界に提供しています。消毒および消毒されたクリーンルームは、オペレーターの介入により汚染される可能性があります。しかし、医薬品アイソレータ業界は汚染を制限し、医薬品と製造材料のみが処理システム全体に接触するバイオ除染状態を提供します。
アイソレータ内部のバイオ除染環境は、作業領域を過酸化水素で洗浄した結果です。自動化されたバイオ除染プロセスにより、医薬品アイソレータの内部で高レベルの消毒剤を繰り返し使用できます。無菌性保証レベル（SAL）は、消毒されたクリーンルームよりもはるかに高く、医薬品アイソレータ市場の成長を効果的に推進します。
- 市場にとって重要な機会
医薬品アイソレータ市場におけるさまざまな技術的進歩により、予測される年の市場成長機会が急増します。現代の技術動向は、製薬アイソレータ業界におけるロボット技術の将来の増加につながるでしょう。製薬産業の製造プロセスでは、ロボット技術の出現によってのみ得られる品質の再現性が高まるため、製造手順を繰り返すことが必須です。
医薬品アイソレータ市場にロボット技術を導入することで、精度だけでなく品質も向上します。そのため、研究および技術部門は、将来、より良い製品アイデアを生み出すために、ロボット技術に常に取り組んでいます。製薬業界におけるロボット技術の浮上により、製薬技術アイソレータ市場もさらに高まるでしょう。
- 市場制約
医薬品アイソレータ市場は、COVID19パンデミックの発生の影響を受け、市場成長の道を大きく抑制する役割を果たしました。産業の製造プロセスは、不確実な期間閉鎖されました。パンデミックの間、世界経済は低迷しました。しかし、厳しい状況でも市場の成長は持続しました。コロナウイルスの発生により、世界中で健康危機が急増し、医薬品の需要が大幅に高まりました。医薬品のニーズの高まりにより、製薬技術アイソレーター市場の需要が高まり、予測期間中の市場の成長につながります。
- 市場成長の課題
Frequently Asked Questions (FAQ) :
The predicted valuation is USD 32,994.3 million by 2027.
The projected CAGR would be 7.86% during the forecast period.
The market valuation was USD 20,876.4 million in 2017.
The market would be led by an open isolator market.
The positive pressure segment would dominate the market.
Company Landscape
There are numerous small and large players operating in the global pharmaceutical isolator market. Some of them include Skan AG, Hosokawa Micron Ltd, Azbil Telstar, Getinge AB, Robert Bosch GmbH, and COMECER S.p.A. cf. p.iva, among others.
Skan AG is one of the prominent players in the market. The company is engaged in developing cleanroom and isolator equipment for the pharmaceutical industry. The company has a global presence with a strong distribution network. Skan AG mainly focuses on strategic partnerships to strengthen its presence globally. For instance, in September 2017, the company signed a partnership with the ITS Group. This partnership aimed at strengthening Skan AG’s presence in the field of isolator technology in Singapore and Indonesia.
Getinge AB is a prominent player operating in the market. The company specializes in medical technology and provides products and solutions to healthcare and life science companies. The company has a worldwide presence with operations in more than 40 countries and sales in about 150 countries. Getinge AB focuses on the development of innovative product portfolio and on strengthening its position in niche segments.
Hosokawa Micron Ltd is also one of the major players in the global market. The company has a diverse range of products. The company focuses on increasing its footprints in the nanoparticle technology segment. Apart from this, the company focuses on manufacturing innovative products.
COMECER S.p.A. cf. p.iva is engaged in the manufacturing of high technology systems in the field of aseptic processing and contaminant for pharmaceutical and nuclear medicine industries. The company has a wide range of products based on the isolation technology. The company mainly focuses on strategic collaborations and mergers. For instance, in May 2018, the company along with its US-based subsidiary, Comecer America, announced a collaboration with Advaxis company to produce an aseptic manufacturing system (isolation technology).
Apart from these companies, there is a large number of companies operating in the pharmaceutical isolator market. These companies are based in different regions such as the Americas, Asia-Pacific, Europe, and the Middle East and Africa. These companies are involved in the development of equipment based on the isolation technology for use in the pharmaceutical and biotechnological industry.
